{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T00:54:20Z","timestamp":1795136060950,"version":"4.10.3"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"48","license":[{"start":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T00:00:00Z","timestamp":1732838400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,11,29]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>This study aimed to assess the impact of the timing of low-dose hydrocortisone adjuvant therapy initiation on clinical outcomes in patients with septic shock by a systematic review and meta-analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We conducted a comprehensive search of all randomized controlled trials (RCTs) and cohort studies available in the PubMed, Web of Science, and Embase databases. The search included articles published from the founding of these databases until August 1, 2024. The purpose of the search was to compare the results of initiating low-dose hydrocortisone (HC) adjuvant therapy at different time periods. The main reported results included short-term mortality (ICU mortality and hospital mortality) as key outcomes, and secondary outcomes such as the rate of renal replacement treatment continuous renal replacement therapy (CRRT), length of stay in the intensive care unit (ICU), and rate of shock reversal.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Seven trials, with a total of 3063 patients, were included. The main finding of this meta-analysis indicates that the early treatment group, which received low-dose hydrocortisone, had a lower ICU mortality rate compared to the late treatment group. Additionally, the hospital mortality rate in the early treatment group was lower than that in the late treatment group. There was a correlation between the timing of beginning of HC and the short-term mortality of patients with septic shock. The secondary findings indicated that there were no notable disparities in the rates of CRRT, the rate of reversing shock, and the duration of stay in the ICU.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Administering low doses of HC early on can decrease the risk of death in septic shock patients in the short-term mortality. There were no substantial disparities observed in the rate of CRRT, the rate of reversal of shock, and the duration of stay in the ICU. Additional extensive RCTs are required to validate this conclusion.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000040635","type":"journal-article","created":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T21:02:05Z","timestamp":1732914125000},"page":"e40635","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Early use of low-dose hydrocortisone can reduce in-hospital mortality in patients with septic shock: A systematic review and meta-analysis"],"prefix":"10.1097","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-8913-7172","authenticated-orcid":false,"given":"Binglin","family":"Song","sequence":"first","affiliation":[{"name":"North Sichuan Medical College, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangde","family":"Zheng","sequence":"additional","affiliation":[{"name":"Emergency Department, Dazhou Central Hospital, Sichuan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangrui","family":"Fu","sequence":"additional","affiliation":[{"name":"North Sichuan Medical College, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Liu","sequence":"additional","affiliation":[{"name":"Emergency Department, Dazhou Central Hospital, Sichuan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250503","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1056\/NEJMoa022139","article-title":"The epidemiology of sepsis in the United States from 1979 through 2000.","volume":"348","author":"Martin","year":"2003","journal-title":"N Engl J Med"},{"key":"R2-20250503","doi-asserted-by":"crossref","first-page":"e1063","DOI":"10.1097\/CCM.0000000000005337","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021.","volume":"49","author":"Evans","year":"2021","journal-title":"Crit Care Med"},{"key":"R3-20250503","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/cc10601","article-title":"Early initiation of low-dose corticosteroid therapy in the management of septic shock: a retrospective observational study.","volume":"16","author":"Park","year":"2012","journal-title":"Crit Care"},{"key":"R4-20250503","first-page":"197","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016.","volume":"18","author":"Andrew","year":"2017","journal-title":"Intensive Care Med"},{"key":"R6-20250503","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/j.ajem.2017.06.004","article-title":"Early initiation of low-dose hydrocortisone treatment for septic shock in adults: a randomized clinical trial.","volume":"35","author":"Lv","year":"2017","journal-title":"Am J Emerg Med"},{"key":"R7-20250503","doi-asserted-by":"crossref","first-page":"36","DOI":"10.7326\/0003-4819-81-1-36","article-title":"Clinical trial design in studies of corticosteroids for bacterial infections.","volume":"81","author":"Weitzman","year":"1974","journal-title":"Ann Intern Med"},{"key":"R8-20250503","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1172\/JCI102441","article-title":"Effect of cortisone on acute streptococcal infections and post-streptococcal complications.","volume":"30","author":"Hahn","year":"1951","journal-title":"J Clin Invest"},{"key":"R9-20250503","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJM198709103171101","article-title":"A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock.","volume":"317","author":"Bone","year":"1987","journal-title":"N Engl J Med"},{"key":"R10-20250503","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1056\/NEJM198709103171102","article-title":"Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis.","volume":"317","year":"1987","journal-title":"N Engl J Med"},{"key":"R11-20250503","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1001\/jama.288.7.862","article-title":"Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.","volume":"288","author":"Annane","year":"2002","journal-title":"JAMA"},{"key":"R12-20250503","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1097\/01.CCM.0000117317.18092.E4","article-title":"Surviving sepsis campaign guidelines for management of severe sepsis and septic shock.","volume":"32","author":"Dellinger","year":"2004","journal-title":"Crit Care Med"},{"key":"R13-20250503","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa071366","article-title":"Hydrocortisone therapy for patients with septic shock.","volume":"358","author":"Sprung","year":"2008","journal-title":"N Engl J Med"},{"key":"R14-20250503","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1705716","article-title":"Hydrocortisone plus fludrocortisone for adults with septic shock.","volume":"378","author":"Annane","year":"2018","journal-title":"N Engl J Med"},{"key":"R15-20250503","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1001\/jamainternmed.2018.5849","article-title":"Association of corticosteroid treatment with outcomes in adult patients with sepsis: a systematic review and meta-analysis.","volume":"179","author":"Fang","year":"2019","journal-title":"JAMA Intern Med"},{"key":"R16-20250503","first-page":"1","article-title":"Corticosteroids for treating sepsis in children and adults.","volume":"2019","author":"Annane","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"R17-20250503","doi-asserted-by":"crossref","first-page":"EVIDoa2300034","DOI":"10.1056\/EVIDoa2300034","article-title":"Patient-level meta-analysis of low-dose hydrocortisone in adults with septic shock.","volume":"2","author":"Pirracchio","year":"2023","journal-title":"NEJM Evid"},{"key":"R18-20250503","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ijsu.2010.02.007","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.","volume":"8","author":"Moher","year":"2010","journal-title":"Int J Surg"},{"key":"R19-20250503","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3).","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"R21-20250503","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses.","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"R22-20250503","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1177\/10600280211021103","article-title":"Comparison of early versus late initiation of hydrocortisone in patients with septic shock in the ICU setting.","volume":"56","author":"Ragoonanan","year":"2022","journal-title":"Ann Pharmacother"},{"key":"R23-20250503","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1097\/CCM.0000000000000318","article-title":"Early administration of hydrocortisone replacement after the advent of septic shock: impact on survival and immune response.","volume":"42","author":"Katsenos","year":"2014","journal-title":"Crit Care Med"},{"key":"R24-20250503","first-page":"e50814","article-title":"Early versus late initiation of hydrocortisone in patients with septic shock: a prospective study.","volume":"15","author":"Alsulami","year":"2023","journal-title":"Cureus"},{"key":"R25-20250503","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1177\/10600280231191131","article-title":"Comparison of early versus late adjunctive vasopressin and corticosteroids in patients with septic shock.","volume":"58","author":"Alshehri","year":"2024","journal-title":"Ann Pharmacother"},{"key":"R26-20250503","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/SHK.0000000000001651","article-title":"Evaluation of the initiation timing of hydrocortisone in adult patients with septic shock.","volume":"55","author":"Sacha","year":"2021","journal-title":"Shock"},{"key":"R27-20250503","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1213\/ANE.0000000000006516","article-title":"The timing of initiating hydrocortisone and long-term mortality in septic shock.","volume":"137","author":"Zhang","year":"2023","journal-title":"Anesth Analg"},{"key":"R29-20250503","first-page":"730","article-title":"Risk factors for lateral cervical lymph node metastasis in medullary thyroid carcinoma.","volume":"50","author":"Wu","year":"2021","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue Ban"},{"key":"R30-20250503","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13643-017-0630-4","article-title":"Quantifying heterogeneity in individual participant data meta-analysis with binary outcomes.","volume":"6","author":"Chen","year":"2017","journal-title":"Syst Rev"},{"key":"R31-20250503","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses.","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"R32-20250503","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1177\/09622802231172043","article-title":"Detecting the skewness of data from the 5-number summary and its application in meta-analysis.","volume":"32","author":"Shi","year":"2023","journal-title":"Stat Methods Med Res"},{"key":"R33-20250503","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJMoa1214969","article-title":"Reduced cortisol metabolism during critical illness.","volume":"368","author":"Boonen","year":"2013","journal-title":"N Engl J Med"},{"key":"R34-20250503","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMe1302305","article-title":"Adrenal dysfunction in critically ill patients.","volume":"368","author":"Gomez-Sanchez","year":"2013","journal-title":"N Engl J Med"},{"key":"R35-20250503","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1097\/CCM.0b013e31825b8ebc","article-title":"Corticosteroid resistance in sepsis is influenced by microRNA-124\u2013induced downregulation of glucocorticoid receptor-\u03b1.","volume":"40","author":"Ledderose","year":"2012","journal-title":"Crit Care Med"},{"key":"R36-20250503","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1046\/j.1365-2125.1998.00833.x","article-title":"Impaired pressor sensitivity to noradrenaline in septic shock patients with and without impaired adrenal function reserve.","volume":"46","author":"Annane","year":"1998","journal-title":"Br J Clin Pharmacol"},{"key":"R37-20250503","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jcrc.2020.02.014","article-title":"Relationship between norepinephrine dose, tachycardia and outcome in septic shock: a multicentre evaluation.","volume":"57","author":"Domizi","year":"2020","journal-title":"J Crit Care"},{"key":"R38-20250503","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/SHK.0000000000000426","article-title":"Norepinephrine: not too much, too long.","volume":"44","author":"Martin","year":"2015","journal-title":"Shock"},{"key":"R39-20250503","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jcrc.2013.09.004","article-title":"Does high-dose vasopressor therapy in medical intensive care patients indicate what we already suspect?","volume":"29","author":"Sviri","year":"2014","journal-title":"J Crit Care"},{"key":"R40-20250503","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1378\/chest.12-1106","article-title":"Survival after shock requiring high-dose vasopressor therapy.","volume":"143","author":"Brown","year":"2013","journal-title":"Chest"},{"key":"R41-20250503","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13613-017-0261-x","article-title":"Outcome of patients with septic shock and high-dose vasopressor therapy.","volume":"7","author":"Auchet","year":"2017","journal-title":"Ann Intensive Care"},{"key":"R42-20250503","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1097\/00003246-200105000-00041","article-title":"Effect of corticosteroids on nuclear factor-\u03baB activation and hemodynamics in late septic shock.","volume":"29","author":"van Leeuwen","year":"2001","journal-title":"Crit Care Med"},{"key":"R43-20250503","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0008-6363(98)00230-2","article-title":"The role of corticosteroids in the regulation of vascular tone.","volume":"41","author":"Ullian","year":"1999","journal-title":"Cardiovasc Res"},{"key":"R44-20250503","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1097\/01.CCM.0000159854.23324.84","article-title":"Absolute and relative adrenal insufficiency in children with septic shock.","volume":"33","author":"Pizarro","year":"2005","journal-title":"Crit Care Med"},{"key":"R45-20250503","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1097\/CCM.0000000000003262","article-title":"Corticosteroids in sepsis: an updated systematic review and meta-analysis.","volume":"46","author":"Rochwerg","year":"2018","journal-title":"Crit Care Med"},{"key":"R46-20250503","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMoa1705835","article-title":"Adjunctive glucocorticoid therapy in patients with septic shock.","volume":"378","author":"Venkatesh","year":"2018","journal-title":"N Engl J Med"},{"key":"R47-20250503","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1001\/jamainternmed.2023.0258","article-title":"Comparative effectiveness of fludrocortisone and hydrocortisone versus hydrocortisone alone among patients with septic shock.","volume":"183","author":"Bosch","year":"2023","journal-title":"JAMA Intern Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000040635","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:03:12Z","timestamp":1746316992000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000040635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,29]]},"references-count":44,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000040635","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,29]]}}}